Skip to main content
Quest Diagnostics

Breast Cancer in PMS2-Positive Patients

NSGC 2020: National Society of Genetic Counselors 39th Virtual Annual Conference
Virtual [in-person conference canceled], November 17-22, 2020

Breast cancer in PMS2-positive patients

Authors: Boehler K, Weltmer EC, Fesko YA, Lacbawan F

Specialties: oncology, genetics

Related content

Publication
Metastatic triple-negative breast carcinoma mimicking melanoma: A potential diagnostic pitfall
Conference Presentation
The Effect of a Digital Health Coaching (DHC) Program on Patient Reported Outcomes of Women with Breast Cancer
Test FAQ
Hereditary Breast Cancer Panel
Test FAQ
BRCA Panel Plus

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2025 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.